ANALYSIS: Medicinal cannabis has been legal since 2016 and while more than one million Australians have been prescribed cannabis products, the industry continues to struggle for profitability.
ANALYSIS: Building franchises trade on trust and reliability, but when the franchisee fails the customer protections are mixed.
ANALYSIS: More Kiwi companies are looking to the ASX for listing, but is the grass really greener over the Ditch for newer, smaller firms looking for capital?
ANALYSIS: What might a comprehensive review of the Companies Act look like?
ANALYSIS: While cuts next year still look likely, days of 0.25% official cash rate set to become stuff of folklore.
ANALYSIS: New Zealand and Australia feel the freeze from dwindling Chinese demand.
ANALYSIS: Shoeshine muses on AI commentary from Google’s top brass down to hackathon participants.
ANALYSIS: Whatever effect the unpopular mortgage non-deductibility rule is having, it isn’t pushing up rents.
ANALYSIS: The board is trying to move on from a dismissed takeover bid, but can it?
ANALYSIS: Residents query a change in residential visitor accommodation for some but not all at the luxury Queenstown development.